Given the risks of reduced disease-free survival and overall survival associated with obesity and weight gain among breast cancer survivors, it is important to understand the relationship between lifestyle interventions which result in weight loss and serum ghrelin levels among this population8,9,27. Here, GHRL is linked to obesity due to melanocortin 4 receptor deficiency.